18-year survivor discusses HIV battle fatigue.
David Morris, 47, is the very picture of successful HIV antiretroviral therapy. He was diagnosed with HIV on Dec. 31, 1983, first began to take AZT in 1985, and now is on an antiretroviral regimen that has kept his viral load to undetectable levels. Moreover, Morris has thus far avoided some of the more serious side effects associated with treatment, including lipodystrophy, bone problems, and increased lipid levels. However, Morris, who is an administrator of the wellness program at Beth Israel Deaconess Medical Center in Boston, sometimes feels as though he is suffering from battle fatigue.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology*; D012944:Social Support
D019380:Anti-HIV Agents